Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-175544

Xenbase Image ID: 175544


Figure 6: The expression of first and second heart field markers is affected by Kmt2d loss of function. Embryos were injected with 2.5 ng MO (Kmt2d or 5 bp mismatch control) in combination with 100 pg LacZ RNA in one dorsal blastomere at the 4-cell stage and analyzed by Tbx20 or Isl1 in situ hybridization. A Schematic drawing of Tbx20 expression in the first heart field at stage 29. B-E Embryos analyzed by Tbx20 in situ hybridization shown from the ventral side; asterisks indicate the injected side. B Uninjected control embryo. C Embryo injected with mismatch control MO. D,E Kmt2d morphant embryos showing a reduction as well as a posterior shift of Tbx20 expressing cells on the injected side. F Graph summarizing three independent injection experiments, standard errors of the means and numbers of analyzed embryos are indicated for each column. *** P-value in a Student’s t-test < 0.001. G Schematic drawing of Isl1 expression in the second heart field at stage 29. H-K Embryos analyzed by Isl1 in situ hybridization. H Uninjected control. I Mismatch control. J,K Kmt2d morphants with reduced expression of Isl1. L Graph summarizing three independent experiments, s.e.m as well as numbers of analyzed embryos are indicated. ** P-value in a Student’s t-test < 0.01.

Image published in: Schwenty-Lara J et al. (2019)

Copyright © 2019. Image reproduced with permission of the Publisher, John Wiley & Sons.

GeneSynonymsSpeciesStage(s)Tissue
tbx20.LXTBX20X. laevisSometime during NF stage 1 to NF stage 29 and 30primary heart field
isl1.Lislet-1, islet1, Xisl-1, Xislet-1X. laevisThroughout NF stage 29 and 30secondary heart field

Image source: Published

Experiment + Assay Source Phenotypes and Disease
Xla Wt + kmt2d MO + NF29/30 (in situ hybridization) Fig. 6 D E F
Anatomical Phenotype
abnormal development of primary heart field
Disease
congenital heart disease
Kabuki syndrome
Expression Phenotype
decreased amount tbx20.L expression in primary heart field
Xla Wt + kmt2d MO + NF29/30 (in situ hybridization) Fig. 6 J K L
Anatomical Phenotype
abnormal development of secondary heart field
Disease
congenital heart disease
Kabuki syndrome
Expression Phenotype
decreased amount isl1.L expression in secondary heart field

Larger Image
Printer Friendly View

Return to previous page